Beijing BIOOCUS Biotech Ltd. presents its innovative product, TIL Companies, a technology that harnesses the power of T cell therapy to treat cancer. TIL, or tumor-infiltrating lymphocytes, are a type of white blood cell that can recognize and destroy cancer cells. This groundbreaking technology involves the extraction of TILs from a patient's tumor, followed by their expansion in the laboratory and reinfusion into the patient to target and eliminate the cancer cells, With TIL Companies, Beijing BIOOCUS Biotech Ltd. is at the forefront of the biotechnology industry, offering a cutting-edge solution for cancer treatment. This personalized approach to therapy has shown promising results in clinical trials, with the potential to revolutionize the way we combat cancer
Please feel free to give your inquiry in the form below We will reply you in 24 hours